2 results
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Durvalumab after ... Progression-free Survival ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival ... #EBM #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM